News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NCDSER Purchases Instem’s Provantis Preclinical Software Suite


7/16/2014 9:13:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that the National Shanghai Center for Drug Safety Evaluation and Research (NCDSER), also known as Shanghai InnoStar Bio-Tech Co. Ltd., has purchased the Provantis® preclinical software suite to automate laboratory processes at their R&D facility in the Zhangjiang Hi-Tech Park, Pudong, Shanghai, China.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
Instem
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES